Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06843538 · ClinicalTrials.gov registry record · Phase 3
Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery
A Phase 3 study of Postoperative Urinary Retention (POUR), sponsored by TriHealth.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 166
- Enrollment target
- 1
- Study location
NCT06843538: Recruiting Phase 3 study of Postoperative Urinary Retention (POUR), sponsored by TriHealth.
NCT06843538 is a Phase 3 study of Postoperative Urinary Retention (POUR) that is actively recruiting participants, run by TriHealth. The registered enrollment target is 166 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06843538, a Phase 3 study of Postoperative Urinary Retention (POUR), is actively recruiting participants, sponsored by TriHealth.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 166 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine from the bladder into a collection bag).
Primary Outcome
Whether or not patients pass or fail their postoperative voiding trial
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Tamsulosin
Study Locations (1)
Ohio
- TriHealth - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2025-02-03 |
| Est. Completion | 2026-06-01 |
| Phase | Phase 3 |
What NCT06843538 shows while recruiting
NCT06843538 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Postoperative Urinary Retention (POUR) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06843538 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06843538 about?
NCT06843538 is a clinical study titled "Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery". The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine from the bladder into a collection bag).
What is the current status of trial NCT06843538?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 166 participants. The study started on 2025-02-03. Estimated completion is 2026-06-01.
What conditions does trial NCT06843538 study?
This clinical trial studies the following conditions: Postoperative Urinary Retention (POUR).
What interventions are being tested in trial NCT06843538?
The interventions under investigation include: Placebo (DRUG), Tamsulosin (DRUG).
Who is sponsoring clinical trial NCT06843538?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06843538 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06843538's enrollment target sits among peer trials
166 1464th of 2000 higher than 536 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI